Clinical Trials Logo
  1. Home
  2. Eyelash Hypotrichosis
  3. NCT01229423

Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

Eyelash Hypotrichosis Clinical Trial

Clinical Trial Summary

This study will evaluate the safety and efficacy of LATISSE® (bimatoprost 0.03%) in the augmentation of eyelashes in Korean women.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01229423
Study type Interventional
Source Allergan
Contact
Status Completed
Phase Phase 4
Start date November 2009
Completion date October 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT01623479 - An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
Completed NCT01064882 - Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence Phase 2
Completed NCT01023841 - Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children Phase 4
Completed NCT01391273 - Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis Phase 3
Completed NCT01391286 - Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis Phase 3
Completed NCT02505776 - Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan